New Test Announcements

• Follicle Stimulating Hormone (FSH) Test Methodology Change
• Alpha-Fetoprotein Tumor Marker (AFP) Test Methodology Change
• CA 125 Test Methodology Change
• Prolactin (PRL) Test Methodology Change
• Herpes Simplex Virus Testing Changes

• AmniSure (Rupture of Fetal Membrane)
• Hepatitis C RIBA
  
  
• Test Methodology Change
• Prealbumin Test Methodology Change
• Clearview iFOB Complete Test Recall
• Ammonia Test Methodology Change
• Glucose Challenge
• Estradiol Reference Range Change
• Hepatitis C RIBA Test Obsolete
• Creatine Kinase (CK) Test Methodology Change
• LAP Test Obsolete
• Treponema pallidum reflexive to RPR

• Celiac Disease Cascade
• HPV High-Risk Reflex Testing for ASCUS or LGSIL
• Lactate Dehydrogenase (LD) Test Methodology Change

• Testosterone Reference Range Change
• Anaplasma phagocytophilum/Ehrlichia chaffeensis & other Tick-Borne Illnesses
• Folate RBC
• Fecal Occult Blood, New Immunochemical Procedure
• Rapid Staph aureus and Methicillin susceptibility PCR
• RBC Reference Range Change
• HPV High-Risk Screening

• Body Fluid Analysis

• Rapid Staph aureus Determination from Positive Blood Cultures
• Group B Streptococcus (GBS) Testing by PCR

• CBC Renaming Announcement
• New Tube Labeling Description
• Specimen Retention Requirements

• Lipase Reference Range Change
• Vancomycin Trough Therapeutic Range

• Clostridium difficile toxin Method Change
• hsCRP Test Methodology Change
• Lactoferrin, Stool Methodology Change
• CRP, Serum Change in Unit of Measurement

• Ferritin Test Methodology Change
• Estradiol Test Methodology Change
• PSA Test Methodology Change
• TSH and FT3 Test Methodology Change
• Vitamin B12 Test Methodology Change